Quantitative effect of natural killer-cell licensing on hepatocellular carcinoma recurrence after curative hepatectomy

• Published in: Cancer immunology research 2014-12, Vol.2 (12), p.1142-1147
• Main Authors: Tanimine, Naoki, Tanaka, Yuka, Kobayashi, Tsuyoshi, Tashiro, Hirotaka, Miki, Daiki, Imamura, Michio, Aikata, Hiroshi, Tanaka, Junko, Chayama, Kazuaki, Ohdan, Hideki
• Format: Article
• Language: English
• Subjects: Aged; Aged, 80 and over; Carcinoma, Hepatocellular - genetics; Carcinoma, Hepatocellular - immunology; Carcinoma, Hepatocellular - mortality; Carcinoma, Hepatocellular - pathology; Carcinoma, Hepatocellular - surgery; Female; Follow-Up Studies; Genotype; Hepatectomy; Histocompatibility Antigens - genetics; Histocompatibility Antigens - immunology; Humans; Killer Cells, Natural - immunology; Killer Cells, Natural - metabolism; Liver Neoplasms - genetics; Liver Neoplasms - immunology; Liver Neoplasms - mortality; Liver Neoplasms - pathology; Liver Neoplasms - surgery; Male; Middle Aged; Neoplasm Grading; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prognosis; Receptors, KIR - genetics; Tumor Burden
• ISSN: 2326-6066; 2326-6074
• DOI: 10.1158/2326-6066.cir-14-0091

Natural killer (NK) cells have a potential role in immune surveillance of hepatocellular carcinoma (HCC). Self-recognition of human leukocyte antigens (HLA) through killer immunoglobulin-like receptors (KIR) confers competence to NK cells-a process termed "licensing." We investigated the effect of NK-cell licensing on the susceptibility of patients to HCC recurrence. A total of 170 Japanese patients with HCC who underwent primary curative hepatectomy between 1996 and 2010 were enrolled in this study. The median follow-up period was 5.4 years. We analyzed their KIR-HLA genotypes with sequence-specific polymorphism-based typing and estimated their susceptibility to HCC recurrence by performing propensity score-matching analyses. The presence of KIR2DL1-C2, KIR2DL2-C1, KIR3DL1-BW4, or KIR3DL2-A3/11, functional compound genotypes that intrinsically license NK cells, did not markedly affect HCC recurrence. However, the multiplicity of those compound KIR-HLA genotypes was significantly associated with the HCC recurrence rate, i.e., the cumulative risk of recurrence in patients with at least three compound genotypes was significantly lower than that in patients with one or two compound genotypes, suggesting that the effect of NK-cell licensing on HCC recurrence is quantitative. Patients at high risk of HCC recurrence after curative hepatectomy could be identified by KIR-HLA genotyping.